Confronto

Pasireotid vs. Sekretin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

396091-73-9

nessun dato

Peso molecolare

1047.21 g/mol

3055.5 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Pasireotid

Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.

Sekretin

Secretin binds the Gs-coupled secretin receptor (SCTR) on pancreatic duct cells, opens CFTR chloride channels and triggers secretion of bicarbonate-rich pancreatic fluid and bile flow.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Pasireotid	Sekretin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Pasireotid and Sekretin?: Pasireotid is classified as "Ricerca (altro)", while Sekretin is classified as "Ricerca (altro)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Pasireotid or Sekretin?: The highest available evidence level is "RCT sull'uomo" for Pasireotid and "Studio sull'uomo" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Pasireotid and Sekretin in Germany and the United States?: Germania: Pasireotid — Su prescrizione, Sekretin — Su prescrizione. Stati Uniti: Pasireotid — Su prescrizione, Sekretin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Pasireotid

Sekretin

Germania

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Pasireotid and Sekretin?

Pasireotid is classified as "Ricerca (altro)", while Sekretin is classified as "Ricerca (altro)". Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Pasireotid or Sekretin?

The highest available evidence level is "RCT sull'uomo" for Pasireotid and "Studio sull'uomo" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Pasireotid and Sekretin in Germany and the United States?

Germania: Pasireotid — Su prescrizione, Sekretin — Su prescrizione. Stati Uniti: Pasireotid — Su prescrizione, Sekretin — Su prescrizione. These are factual summaries with source and review date on the individual pages.